LABETALOL HYDROCHLORIDE
Generic: LABETALOL HYDROCHLORIDE
Onesource Specialty Pharma LimitedManufacturer
INTRAVENOUSRoute
LABETALOL HYDROCHLORIDEActive Substance
2010-02-03Original Approval
LABETALOL HYDROCHLORIDE is FDA application ANDA079134, sponsored by ONESOURCE SPECIALTY. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2018-02-20
Labetalol Hydrochloride Injection, USP, 100 mg/ 20 mL (5 mg/mL), 20 mL Multidose Vial, Rx only, labeled as a) Hospira, IDefective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and cri
Class II2014-05-16
Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/cartPresence of Particulate Matter; metal embedded in the glass vial and visible particles floating in t
Class II2024-05-20
Labetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile Cartridge Unit with LuLack of Assurance of Sterility-The potential for incomplete crimp seals.
Top Reported Reactions
1
DRUG INEFFECTIVE
1,060 reports
2
MATERNAL EXPOSURE DURING PREGNANCY
1,001 reports
3
FOETAL EXPOSURE DURING PREGNANCY
976 reports
4
HYPERTENSION
767 reports
5
PREMATURE BABY
752 reports
6
OFF LABEL USE
726 reports
7
EXPOSURE DURING PREGNANCY
672 reports
8
CHRONIC KIDNEY DISEASE
646 reports
9
ACUTE KIDNEY INJURY
645 reports
10
FATIGUE
616 reports